Armored RNA Quant^® SARS-CoV-2 Controls

In response to COVID-19, Asuragen has developed molecular diagnostic controls for multiple regions of the SARS-CoV-2 genome as well as conserved mutations in the spike protein prevalent in the alpha, beta, gamma, delta, and omicron variants. Armored RNA Quant^® controls allow for stable, reliable, and safe ways to rapidly test for the presence of Coronavirus and its variants.

Each control encodes in vitro transcribed RNA encapsulated in a protective protein coat to create a virus-like particle resistant to nuclease degradation. This allows the products to be used as RNA extraction controls, process quality controls or positive diagnostic reference controls. From feasibility to clinical use, these robust and versatile controls are beneficial across all sectors of the research and diagnostic spectrum. Armored Controls have been utilized in FDA-cleared assays for the last 20+ years and continue to serve as an important tool in the rapidly evolving space of molecular diagnostics.